Full View

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus‐Induced Hepatocellular Carcinoma Treated with PD‐1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu… - Journal of Immunology …, 2022 - Wiley Online Library
Purpose. To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)‐induced hepatocellular carcinoma (HCC) treated with PD‐1 inhibitors. Patients …
被引用次数：17 相关文章

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Purpose To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …
[PDF] scienceopen.com

[PDF][PDF] Research Article Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu, J Liu, J Yue - IIb, 2022 - scienceopen.com
Purpose. To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …
[HTML] nih.gov

[HTML][HTML] Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu, J Liu… - Journal of Immunology …, 2022 - ncbi.nlm.nih.gov
Purpose To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …
[PDF] semanticscholar.org

[PDF][PDF] Research Article Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu, J Liu, J Yue - IIb, 2022 - pdfs.semanticscholar.org
Purpose. To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors.

R Huang, Y Zheng, W Zou, C Liu, J Liu… - Journal of Immunology …, 2022 - europepmc.org
Purpose To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu… - Journal of Immunology …, 2022 - search.proquest.com
Purpose. To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors.

R Huang, Y Zheng, W Zou, C Liu… - Journal of Immunology …, 2022 - search.ebscohost.com
Abstract < bold> Purpose: </bold> To investigate the prognostic value of blood
markers in patients with hepatitis B virus (HBV)-induced hepatocellular carcinoma (HCC) …

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors.

R Huang, Y Zheng, W Zou, C Liu, J Liu… - Journal of Immunology …, 2022 - europepmc.org
Purpose To investigate the prognostic value of blood markers in patients with hepatitis B
virus (HBV)-induced hepatocellular carcinoma (HCC) treated with PD-1 inhibitors. Patients …

[引用][C] Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors

R Huang, Y Zheng, W Zou, C Liu, J Liu, J Yue - Journal of Immunology Research - Hindawi